Previous Article | Next Article ![]()
Infect. Immun., Feb 1997, 636-639, Vol 65, No. 2
XD Qu, SS Harwig, WM Shafer and RI Lehrer
Protegrin 1 (PG-1) is a broad-spectrum antimicrobial peptide that contains
18 amino acid residues (RG GRLCYCRRRFCVCVGR) and has two intramolecular
cystine disulfide bonds. To determine the minimal structure responsible for
protegrin-mediated activity against Neisseria gonorrhoeae, we synthesized
15 protegrin variants and tested them against two well-characterized
gonococcal strains. The MICs of PG-1 were 0.61 microM (1.31 microg/ml) for
the serum-sensitive strain F 62 and 0.98 microM (2.11 microg/ml) for the
serum-resistant strain FA 19. Six amino acid residues (Arg1, Gly2, Gly3,
Arg4, Gly17, and Arg18) and either disulfide bond could be deleted from
PG-1 without impairing its potency against strain F 62. In contrast, only
Gly17 and Arg18 could be removed without decreasing its activity against FA
19. Protegrin congener 64a (PC-64a; LTYCRRRFCVTV), a variant of PG-1 with
12 amino acid residues and one disulfide bond, displayed MICs of 0.45
microM (0.68 microg/ml) for strain F 62 and 1.37 microM (2.07 microg/ml)
for strain FA 19, which approximated those of intact PG-1. Serum-sensitive
sac-1+ and sac-3+ transformants of N. gonorrhoeae FA 19 and two FA 19
derivatives with truncated lipooligosaccharide structures were more
susceptible to PG-1 and variants with altered disulfide structures. These
data suggest that structurally simpler protegrin variants, such as PC-64a,
could be used as topical microbicides for N. gonorrhoeae. They also suggest
that the cystine-stabilized antiparallel beta-sheet formed by PG-1 residues
5 to 16 is principally responsible for its activity against gonococci.
Copyright © 1997, American Society for Microbiology
Protegrin structure and activity against Neisseria gonorrhoeae
Department of Medicine, UCLA Center for the Health Sciences, Los Angeles, California 90095-1690, USA.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|